Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Nov 21;92(24):10934–10938. doi: 10.1073/pnas.92.24.10934

Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane.

M Satoh 1, A Kumar 1, Y S Kanwar 1, W H Reeves 1
PMCID: PMC40545  PMID: 7479913

Abstract

The pathogenesis of systemic lupus erythematosus is thought to be primarily under genetic control, with environmental factors playing a secondary role. However, it has been shown recently that intraperitoneal injection of pristane (2,6,10,14-tetramethylpentadecane) induces autoantibodies typical of lupus in BALB/c mice, a strain not usually considered to be genetically susceptible to the disease. In this study, the induction of autoimmune disease by pristane was investigated. BALB/c mice receiving pristane were tested for autoantibody production and histopathological evidence of glomerulonephritis. Six of 11 mice developed IgM anti-single-stranded DNA antibodies shortly after receiving pristane and 4 developed IgM anti-histone antibodies, but anti-double-stranded DNA antibodies were absent. IgG anti-DNA and anti-histone antibodies were absent. In contrast, the lupus-associated anti-nuclear ribonucleoprotein/Sm and anti-Su autoantibodies produced by these mice were predominantly IgG. In addition to autoantibodies, most of the mice developed significant proteinuria. Light microscopy of the kidney showed segmental or diffuse proliferative glomerulonephritis. Electron microscopy showed subepithelial and mesangial immune-complex deposits and epithelial foot process effacement. Immunofluorescence revealed striking glomerular deposition of IgM, IgG, and C3 with a mesangial or mesangiocapillary distribution. Thus, pristane induces immune-complex glomerulonephritis in association with autoantibodies typical of lupus in BALB/c mice. These data support the idea that lupus is produced by an interplay of genetic and environmental factors and that unlike the MRL or (NZB x W)F1 mouse models, in which genetic susceptibility factors are of primary importance, environmental factors are of considerable importance in the autoimmune disease of pristane-treated BALB/c mice.

Full text

PDF
10934

Images in this article

10936Fig. 3
on p.10936
10937Fig. 4
on p.10937

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Block S. R., Winfield J. B., Lockshin M. D., D'Angelo W. A., Christian C. L. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med. 1975 Oct;59(4):533–552. doi: 10.1016/0002-9343(75)90261-2. [DOI] [PubMed] [Google Scholar]
  2. Bloom D. D., Davignon J. L., Cohen P. L., Eisenberg R. A., Clarke S. H. Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J Immunol. 1993 Feb 15;150(4):1579–1590. [PubMed] [Google Scholar]
  3. Casali P., Burastero S. E., Balow J. E., Notkins A. L. High-affinity antibodies to ssDNA are produced by CD-B cells in systemic lupus erythematosus patients. J Immunol. 1989 Dec 1;143(11):3476–3483. [PubMed] [Google Scholar]
  4. Casali P., Burastero S. E., Nakamura M., Inghirami G., Notkins A. L. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science. 1987 Apr 3;236(4797):77–81. doi: 10.1126/science.3105056. [DOI] [PubMed] [Google Scholar]
  5. Eisenberg R. A., Craven S. Y., Cohen P. L. Isotype progression and clonality of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J Immunol. 1987 Aug 1;139(3):728–733. [PubMed] [Google Scholar]
  6. Eisenberg R. A., Pisetsky D., Cohen P. L. Antinuclear antibodies and nuclear antigens in NZB myeloma ascitic fluids. Clin Immunol Immunopathol. 1985 Jun;35(3):337–345. doi: 10.1016/0090-1229(85)90094-7. [DOI] [PubMed] [Google Scholar]
  7. Fatenejad S., Mamula M. J., Craft J. Role of intermolecular/intrastructural B- and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12010–12014. doi: 10.1073/pnas.90.24.12010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fisher D. E., Conner G. E., Reeves W. H., Blobel G., Kunkel H. G. Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation. Proc Natl Acad Sci U S A. 1983 Oct;80(20):6356–6360. doi: 10.1073/pnas.80.20.6356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hang L. M., Aguado M. T., Dixon F. J., Theofilopoulos A. N. Induction of severe autoimmune disease in normal mice by simultaneous action of multiple immunostimulators. J Exp Med. 1985 Feb 1;161(2):423–428. doi: 10.1084/jem.161.2.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hardin J. A. The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum. 1986 Apr;29(4):457–460. doi: 10.1002/art.1780290401. [DOI] [PubMed] [Google Scholar]
  11. Hayakawa K., Hardy R. R. Normal, autoimmune, and malignant CD5+ B cells: the Ly-1 B lineage? Annu Rev Immunol. 1988;6:197–218. doi: 10.1146/annurev.iy.06.040188.001213. [DOI] [PubMed] [Google Scholar]
  12. Ho F. C., Fu K. H. A new model of AA-amyloidosis induced by oral pristane in BALB/c mice. Br J Exp Pathol. 1987 Jun;68(3):413–420. [PMC free article] [PubMed] [Google Scholar]
  13. Horii Y., Muraguchi A., Iwano M., Matsuda T., Hirayama T., Yamada H., Fujii Y., Dohi K., Ishikawa H., Ohmoto Y. Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol. 1989 Dec 15;143(12):3949–3955. [PubMed] [Google Scholar]
  14. Hultman P., Bell L. J., Eneström S., Pollard K. M. Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice. Clin Immunol Immunopathol. 1993 Jul;68(1):9–20. doi: 10.1006/clin.1993.1088. [DOI] [PubMed] [Google Scholar]
  15. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med. 1994 Jan 1;179(1):305–310. doi: 10.1084/jem.179.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Izui S., Lambert P. H., Fournié G. J., Türler H., Miescher P. A. Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identificantion of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med. 1977 May 1;145(5):1115–1130. doi: 10.1084/jem.145.5.1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kiberd B. A. Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol. 1993 Jul;4(1):58–61. doi: 10.1681/ASN.V4158. [DOI] [PubMed] [Google Scholar]
  18. Klinman D. M., Eisenberg R. A., Steinberg A. D. Development of the autoimmune B cell repertoire in MRL-lpr/lpr mice. J Immunol. 1990 Jan 15;144(2):506–511. [PubMed] [Google Scholar]
  19. Koffler D., Agnello V., Kimkel H. G. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol. 1974 Jan;74(1):109–124. [PMC free article] [PubMed] [Google Scholar]
  20. Lewis E. J., Kawala K., Schwartz M. M. Histologic features that correlate with the prognosis of patients with lupus nephritis. Am J Kidney Dis. 1987 Sep;10(3):192–197. doi: 10.1016/s0272-6386(87)80174-9. [DOI] [PubMed] [Google Scholar]
  21. Makino H., Lelongt B., Kanwar Y. S. Nephritogenicity of proteoglycans. II. A model of immune complex nephritis. Kidney Int. 1988 Aug;34(2):195–208. doi: 10.1038/ki.1988.165. [DOI] [PubMed] [Google Scholar]
  22. McDonald A. H., Degrassi A. Pristane induces an indomethacin inhibitable inflammatory influx of CD4+ T cells and IFN-gamma production in plasmacytoma-susceptible BALB/cAnPt mice. Cell Immunol. 1993 Jan;146(1):157–170. doi: 10.1006/cimm.1993.1014. [DOI] [PubMed] [Google Scholar]
  23. Mendlovic S., Brocke S., Shoenfeld Y., Ben-Bassat M., Meshorer A., Bakimer R., Mozes E. Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2260–2264. doi: 10.1073/pnas.85.7.2260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Mohan C., Adams S., Stanik V., Datta S. K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. doi: 10.1084/jem.177.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Nordan R. P., Potter M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science. 1986 Aug 1;233(4763):566–569. doi: 10.1126/science.3726549. [DOI] [PubMed] [Google Scholar]
  26. O'Garra A., Chang R., Go N., Hastings R., Haughton G., Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol. 1992 Mar;22(3):711–717. doi: 10.1002/eji.1830220314. [DOI] [PubMed] [Google Scholar]
  27. Pisetsky D. S. Anti-DNA antibodies in systemic lupus erythematosus. Rheum Dis Clin North Am. 1992 May;18(2):437–454. [PubMed] [Google Scholar]
  28. Rabin E., Cong Y. Z., Wortis H. H. Loss of CD23 is a consequence of B-cell activation. Implications for the analysis of B-cell lineages. Ann N Y Acad Sci. 1992 May 4;651:130–142. doi: 10.1111/j.1749-6632.1992.tb24602.x. [DOI] [PubMed] [Google Scholar]
  29. Reap E. A., Sobel E. S., Cohen P. L., Eisenberg R. A. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J Exp Med. 1993 Jan 1;177(1):69–78. doi: 10.1084/jem.177.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Reeves W. H., Kanwar Y. S., Farquhar M. G. Assembly of the glomerular filtration surface. Differentiation of anionic sites in glomerular capillaries of newborn rat kidney. J Cell Biol. 1980 Jun;85(3):735–753. doi: 10.1083/jcb.85.3.735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Reuter R., Tessars G., Vohr H. W., Gleichmann E., Lührmann R. Mercuric chloride induces autoantibodies against U3 small nuclear ribonucleoprotein in susceptible mice. Proc Natl Acad Sci U S A. 1989 Jan;86(1):237–241. doi: 10.1073/pnas.86.1.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ryffel B., Car B. D., Gunn H., Roman D., Hiestand P., Mihatsch M. J. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice. Am J Pathol. 1994 May;144(5):927–937. [PMC free article] [PubMed] [Google Scholar]
  33. Sabbaga J., Line S. R., Potocnjak P., Madaio M. P. A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol. 1989 Jan;19(1):137–143. doi: 10.1002/eji.1830190122. [DOI] [PubMed] [Google Scholar]
  34. Satoh M., Langdon J. J., Chou C. H., McCauliffe D. P., Treadwell E. L., Ogasawara T., Hirakata M., Suwa A., Cohen P. L., Eisenberg R. A. Characterization of the Su antigen, a macromolecular complex of 100/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol. 1994 Oct;73(1):132–141. doi: 10.1006/clin.1994.1179. [DOI] [PubMed] [Google Scholar]
  35. Satoh M., Reeves W. H. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994 Dec 1;180(6):2341–2346. doi: 10.1084/jem.180.6.2341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Satoh M., Treadwell E. L., Reeves W. H. Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice. Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera. J Immunol Methods. 1995 May 11;182(1):51–62. doi: 10.1016/0022-1759(95)00022-3. [DOI] [PubMed] [Google Scholar]
  37. Schubert D., Roman A., Cohn M. Anti-nucleic acid specificites of mouse myeloma immunoglobulins. Nature. 1970 Jan 10;225(5228):154–158. doi: 10.1038/225154a0. [DOI] [PubMed] [Google Scholar]
  38. Shacter E., Arzadon G. K., Williams J. Elevation of interleukin-6 in response to a chronic inflammatory stimulus in mice: inhibition by indomethacin. Blood. 1992 Jul 1;80(1):194–202. [PubMed] [Google Scholar]
  39. Suematsu S., Matsuda T., Aozasa K., Akira S., Nakano N., Ohno S., Miyazaki J., Yamamura K., Hirano T., Kishimoto T. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7547–7551. doi: 10.1073/pnas.86.19.7547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Theofilopoulos A. N. The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today. 1995 Mar;16(3):150–159. doi: 10.1016/0167-5699(95)80133-2. [DOI] [PubMed] [Google Scholar]
  41. Thompson S. J., Rook G. A., Brealey R. J., Van der Zee R., Elson C. J. Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol. 1990 Nov;20(11):2479–2484. doi: 10.1002/eji.1830201118. [DOI] [PubMed] [Google Scholar]
  42. Treadwell E. L., Cohen P., Williams D., O'Brien K., Volkman A., Eisenberg R. MRL mice produce anti-Su autoantibody, a specificity associated with systemic lupus erythematosus. J Immunol. 1993 Jan 15;150(2):695–699. [PubMed] [Google Scholar]
  43. Tsao B. P., Ebling F. M., Roman C., Panosian-Sahakian N., Calame K., Hahn B. H. Structural characteristics of the variable regions of immunoglobulin genes encoding a pathogenic autoantibody in murine lupus. J Clin Invest. 1990 Feb;85(2):530–540. doi: 10.1172/JCI114469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Vlahakos D. V., Foster M. H., Adams S., Katz M., Ucci A. A., Barrett K. J., Datta S. K., Madaio M. P. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992 Jun;41(6):1690–1700. doi: 10.1038/ki.1992.242. [DOI] [PubMed] [Google Scholar]
  45. Watson M. L., Rao J. K., Gilkeson G. S., Ruiz P., Eicher E. M., Pisetsky D. S., Matsuzawa A., Rochelle J. M., Seldin M. F. Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J Exp Med. 1992 Dec 1;176(6):1645–1656. doi: 10.1084/jem.176.6.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Wooley P. H., Seibold J. R., Whalen J. D., Chapdelaine J. M. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 1989 Aug;32(8):1022–1030. doi: 10.1002/anr.1780320812. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES